The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients

Abstract

IntroductionHLA-B*35 is associated with increased risk of developing pulmonary hypertension in SSc patients. We previously reported that HLA-B*35 induces endothelial cell dysfunction via activation of ER stress/UPR and upregulation of the inflammatory response. Because PBMCs from lcSSc-PAH patients are also characterized by activation of ER stress/UPR and inflammation, the goal of this study was to assess whether the presence of HLA-B*35 contributes to those characteristics.MethodsPBMCs were purified from healthy controls (n = 49 HC) and lcSSc patients, (n = 44 with PAH, n = 53 without PAH). PBMCs from each group were stratified for the presence of HLA-B*35. Global changes in gene expression in response to HLA-B*35, HLA-B*8 or empty lentivirus were investigated by microarray analysis in HC PBMCs. Total RNA was extracted and qPCR was performed to measure gene expression.ResultsER stress markers, in particular the chaperones BiP and DNAJB1 were significantly elevated in PBMC samples carrying the HLA-B*35 allele. IL-6 expression was also significantly increased in HLA-B*35 lcSSc PBMCs and positively correlated with ER stress markers. Likewise, HMGB1 was increased in HLA-B*35-positive lcSSc PBMCs. Global gene expression analysis was used to further probe the role of HLA-B*35. Among genes downregulated by HLA-B*35 lentivirus were genes related to complement (C1QB, C1QC), cell cycle (CDNK1A) and apoptosis (Bax, Gadd45). Interestingly, complement genes (C1QC and C1QB) showed elevated expression in lcSSc without PAH, but were expressed at the low levels in lcSSc-PAH. The presence of HLA-B*35 correlated with the decreased expression of the complement genes. Furthermore, HLA-B*35 correlated with decreased expression of cyclin inhibitors (p21, p57) and pro-apoptotic genes (Bax, Gadd45) in lcSSc B35 subjects. FYN, a tyrosine kinase involved in proliferation of immune cells, was among the genes that were positively regulated by HLA-B*35. HLA-B*35 correlated with increased levels of FYN in lcSSc PBMCs.ConclusionsOur study demonstrates that HLA-B*35 contributes to the dysregulated expression of selected ER stress, inflammation and proliferation related genes in lcSSc patient PBMCs, as well as healthy individuals, thus supporting a pathogenic role of HLA-B*35 in the development of PAH in SSc patients.Electronic supplementary materialThe online version of this article (doi:10.1186/s13075-015-0881-1) contains supplementary material, which is available to authorized users.

Allelic imbalance of HLA-B expression in human lung cells infected with coronavirus and other respiratory viruses

“…Previous reports point toward an important role of HLA-B alleles in mediating the most effective antiviral immunity [ 14 , 37 ]. Lenna et al also reported that HLA-B alleles have distinct capability in inducing the expression of some immune-related genes in lymphocytes [ 38 ]. Meanwhile, our and other in silico studies [ 17 ] have shown that HLA-B proteins carrying different alleles may have different antigen binding affinity.…”

Describing the Clinical and Laboratory Features and HLA-B Pattern of Adult-Onset Idiopathic Autoimmune Uveitis at a Tertiary Hospital in South India: A Cross-Sectional Study

“…We did not find any previous report of the association of retinal vasculitis with HLA-B * 35. HLA-B * 35 is responsible for endoplasmic reticulum stress response by upregulation of endothelin 1 and downregulation of nitric oxide in endothelial cells of pulmonary vasculature [34].…”

Association ofMICAand HLA‐B alleles with leprosy in two endemic populations in Brazil

“…In the same way, MICA alleles could lead to a different pattern of NK cell response (Bauer et al., 1999; Groh et al., 1996; Hüe et al., 2003). It is known the presence of the HLA‐B*35 allele may favour the proliferation of immune cells, contributing to an increased inflammatory response (Lenna et al., 2015). Additionally, HLA alleles are usually associated with cytotoxic T‐cell responses (Mi et al., 2020).…”